These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32752563)

  • 1. Recent Updates to the Advisory Committee On Immunization Practices Recommendations for Pneumococcal and Herpes Zoster Vaccination.
    Brotherton AL; Shah R
    R I Med J (2013); 2020 Aug; 103(6):34-37. PubMed ID: 32752563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What are the new vaccination recommendations for herpes zoster?
    Mospan CM; Colvin N
    JAAPA; 2018 Oct; 31(10):14-15. PubMed ID: 30252758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
    Lu PJ; Euler GL; Harpaz R
    Am J Prev Med; 2011 Feb; 40(2):e1-6. PubMed ID: 21238856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the advisory committee on immunization practices' recommendations for use of herpes zoster vaccine.
    Weaver BA;
    J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S31-3. PubMed ID: 22086893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Advisory Committee on Immunization Practices
    MMWR Recomm Rep; 2000 Oct; 49(RR-9):1-35. PubMed ID: 11055835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines.
    Dooling KL; Guo A; Patel M; Lee GM; Moore K; Belongia EA; Harpaz R
    MMWR Morb Mortal Wkly Rep; 2018 Jan; 67(3):103-108. PubMed ID: 29370152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Nuorti JP; Whitney CG;
    MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What are the latest recommendations for pneumococcal vaccines?
    Fabel PH; Horton EC; Shealy K
    JAAPA; 2016 Apr; 29(4):13-4. PubMed ID: 27023652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update From the Advisory Committee on Immunization Practices.
    O'leary ST; Maldonado YA; Kimberlin DW
    J Pediatric Infect Dis Soc; 2019 Dec; 8(6):495-500. PubMed ID: 31589289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
    Lu PJ; Euler GL; Jumaan AO; Harpaz R
    Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines for older adults.
    Lam S; Jodlowski TZ
    Consult Pharm; 2009 May; 24(5):380-91. PubMed ID: 19555147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of the Recommendations of the Advisory Committee on Immunization Practices for the Recombinant Adjuvanted Zoster Subunit Vaccine.
    Le P; Rothberg MB
    JAMA Intern Med; 2018 Sep; 178(9):1277-1278. PubMed ID: 29987323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    Anderson TC; Masters NB; Guo A; Shepersky L; Leidner AJ; Lee GM; Kotton CN; Dooling KL
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(3):80-84. PubMed ID: 35051134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine.
    Tseng HF; Smith N; Sy LS; Jacobsen SJ
    Vaccine; 2011 May; 29(20):3628-32. PubMed ID: 21435407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of factors associated with influenza, pneumoccocal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability.
    La EM; Trantham L; Kurosky SK; Odom D; Aris E; Hogea C
    Hum Vaccin Immunother; 2018 Feb; 14(2):430-441. PubMed ID: 29194019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shingles Vaccination Among Adults Aged 60 and Over: United States, 2018.
    Terlizzi EP; Black LI
    NCHS Data Brief; 2020 Jul; (370):1-8. PubMed ID: 32730737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination among Medicare-fee-for service beneficiaries: Characteristics and predictors of vaccine receipt, 2014-2017.
    Shen AK; Warnock R; Selna W; MaCurdy TE; Chu S; Kelman JA
    Vaccine; 2019 Feb; 37(9):1194-1201. PubMed ID: 30683507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives.
    Wagner A; Weinberger B
    Front Immunol; 2020; 11():717. PubMed ID: 32391017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on recommendations for use of herpes zoster vaccine.
    Hales CM; Harpaz R; Ortega-Sanchez I; Bialek SR;
    MMWR Morb Mortal Wkly Rep; 2014 Aug; 63(33):729-31. PubMed ID: 25144544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated Human and Economic Burden of Four Major Adult Vaccine-Preventable Diseases in the United States, 2013.
    McLaughlin JM; McGinnis JJ; Tan L; Mercatante A; Fortuna J
    J Prim Prev; 2015 Aug; 36(4):259-73. PubMed ID: 26032932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.